| The Science of Obesity Management: An Endocrine Society Scientific Statement |
94 |
| Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions |
86 |
| Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease |
64 |
| Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints |
61 |
| Molecular Actions of PPAR alpha in Lipid Metabolism and Inflammation |
48 |
| Endometriosis |
42 |
| Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans |
39 |
| Melatonin as a Hormone: New Physiological and Clinical Insights |
38 |
| Klinefelter Syndrome: Integrating Genetics, Neuropsychology, and Endocrinology |
38 |
| Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update |
37 |
| Clinical Management of Congenital Hypogonadotropic Hypogonadism |
35 |
| Lessons From the Testosterone Trials |
32 |
| Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm |
31 |
| Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance |
31 |
| Extracellular Vesicles in Human Reproduction in Health and Disease |
30 |
| Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy |
30 |
| Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes |
29 |
| The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk |
28 |
| The Versatile Tanycyte: A Hypothalamic Integrator of Reproduction and Energy Metabolism |
28 |
| Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy |
27 |
| Ovulation: Parallels With Inflammatory Processes |
25 |
| The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway |
25 |
| Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions |
24 |
| Estrogen Receptors: New Directions in the New Millennium |
23 |
| Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond |
22 |
| Endocrinology of Transgender Medicine |
22 |
| The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment |
22 |
| The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance |
22 |
| Emerging Roles for Serotonin in Regulating Metabolism: New Implications for an Ancient Molecule |
22 |
| Paradigms of Dynamic Control of Thyroid Hormone Signaling |
22 |
| Sex and Gender Differences Research Design for Basic, Clinical, and Population Studies: Essentials for Investigators |
22 |
| Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine |
22 |
| Pituitary Diseases and Bone |
21 |
| Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management |
21 |
| Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms |
21 |
| Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders |
21 |
| Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms |
21 |
| The Gut Microbiome Influences Host Endocrine Functions |
21 |
| Growth Hormone Deficiency: Health and Longevity |
19 |
| The Circadian Clock in White and Brown Adipose Tissue: Mechanistic, Endocrine, and Clinical Aspects |
19 |
| Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms |
18 |
| Growth Hormone's Links to Cancer |
18 |
| Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy |
18 |
| Ovarian Follicular Theca Cell Recruitment, Differentiation, and Impact on Fertility: 2017 Update |
17 |
| Gastrointestinal Malabsorption of Thyroxine |
16 |
| Testis Development |
16 |
| The Liver-alpha-Cell Axis and Type 2 Diabetes |
16 |
| X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment |
15 |
| Children Born Small for Gestational Age: Differential Diagnosis, Molecular Genetic Evaluation, and Implications |
15 |
| Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives |
15 |
| Effects of Leptin on the Skeleton |
14 |
| Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment |
14 |
| Two Hormones for One Receptor: Evolution, Biochemistry, Actions, and Pathophysiology of LH and hCG |
14 |
| Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents |
14 |
| 3-IodothyronamineA Thyroid Hormone Metabolite With Distinct Target Profiles and Mode of Action |
13 |
| Aging and the Male Reproductive System |
13 |
| Uterine Glands: Developmental Biology and Functional Roles in Pregnancy |
13 |
| Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review |
12 |
| Regulation of Skeletal Homeostasis |
12 |
| Nuclear Receptors: Recent Drug Discovery for Cancer Therapies |
12 |
| Diabetic Gastroparesis |
12 |
| Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism |
11 |
| The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications |
11 |
| At the Crossroads of Fate-Somatic Cell Lineage Specification in the Fetal Gonad |
11 |
| Delayed Puberty-Phenotypic Diversity, Molecular Genetic Mechanisms, and Recent Discoveries |
11 |
| Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease |
11 |
| Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action |
10 |
| Diagnostic Utility of Molecular and Imaging Biomarkers in Cytological Indeterminate Thyroid Nodules |
10 |
| Potential Clinical Error Arising From Use of HbA(1c) in Diabetes: Effects of the Glycation Gap |
10 |
| The Aging Thyroid: A Reappraisal Within the Geroscience Integrated Perspective |
10 |
| 11 beta-HSD1 in Human Fetal Membranes as a Potential Therapeutic Target for Preterm Birth |
9 |
| Testicular Adrenal Rest Tumors: Current Insights on Prevalence, Characteristics, Origin, and Treatment |
9 |
| Bone Marrow Adiposity: Basic and Clinical Implications |
8 |
| Coupling the Circadian Clock to Homeostasis: The Role of Period in Timing Physiology |
8 |
| Starvation in the Midst of Plenty: Reflections on the History and Biology of Insulin and Leptin |
8 |
| Clinical Guidelines and PTH Measurement: Does Assay Generation Matter? |
8 |
| Management of XY Differences/Disorders of Sex Development (DSD) Throughout Life |
7 |
| Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease |
7 |
| Structural and Functional Biology of Aldo-Keto Reductase Steroid-Transforming Enzymes |
6 |
| Long-Term Endocrine and Metabolic Consequences of Cancer Treatment: A Systematic Review |
6 |
| Central Mechanisms of Glucose Sensing and Counterregulation in Defense of Hypoglycemia |
6 |
| Contemporary Debates in Adult Papillary Thyroid Cancer Management |
6 |
| Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes |
6 |
| The Extending Spectrum of NPC1-Related Human Disorders: From Niemann-Pick C1 Disease to Obesity |
5 |
| Effects of Anorexia Nervosa on Bone Metabolism |
5 |
| The Effects of Bariatric Surgery on Islet Function, Insulin Secretion, and Glucose Control |
4 |
| The Use and Abuse of Growth Hormone in Sports |
4 |
| Gonadotropins and Their Analogs: Current and Potential Clinical Applications |
3 |
| The Kruppel-Like Factors and Control of Energy Homeostasis |
3 |
| The Hippo Signaling Pathway in Pancreatic beta-Cells: Functions and Regulations |
3 |
| Genetics of Human Primary Hypertension: Focus on Hormonal Mechanisms |
2 |
| The Role of Sexual Hormones on the Enteroinsular Axis |
2 |
| Sexual Dimorphism and the Origins of Human Spinal Health |
1 |
